The Question Is Whether To Buy Or Not To Buy Carters Inc (NYSE: CRI)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Carter’s, Inc. Announces Leadership Changes.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Carters Inc is listed on the NYSE as a member of the Consumer Cyclical sector and is a part of the Apparel Retail industry. At the end of the last regular session, the stock closed at $74.71 and fluctuated between $75.26 as its day high and $74.10 as its day low. The current market capitalization of Carters Inc is $2.75B. A total of 0.55 million shares were traded on the day, compared to an average of 684.51K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CRI has seen 4 BUY and 6 SELL insider trades, representing the acquisition of 13,300 and the disposition of 25,612 shares. Over the last 12 months, there were 44 BUYs and 54 SELLs from insiders. Insiders purchased 272,078 shares during that period but sold 69,472.

In the most recent transaction, CASEY MICHAEL DENNIS sold 89,139 shares of CRI for 75.00 per share on Dec 14. After the transaction, the Chairman and CEO now owns 390,731 company shares. In a previous transaction on Dec 08, D’Emilio Julie sold 3,400 shares at 72.50 per share. CRI shares that EVP, Sales owns now total 42,783.

Among the insiders who sold shares, Pivar Ben disposed of 312 shares on Nov 17 at a per-share price of $71.02. This resulted in the SVP, CIO holding 18,298 shares of CRI after the transaction. In another insider transaction, Lynch Brian sold 15,400 shares at $69.93 per share on Nov 03. Company shares held by the President & COO now total 97,900.

Dividend

It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Carters Inc pays an annual dividend of $3.06, resulting in a dividend yield of 4.09%, and it has a price to earnings (P/E) ratio of 13.64. CRI’s most recent ex-dividend date was 11/27/2023 when it declared a $0.75 quarterly dividend that was paid in cash on 12/8/2023. Previously, the company paid the dividend on 9/15/2023 with an ex-dividend date of 8/29/2023. The CRI stock dividend was $0.75 per share in cash.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CRI in the last 3 months, the mean price target is $70.29 with high estimates of $84.00 and low estimates of $60.00. In terms of 52-week highs and lows, CRI has a high of $86.76 and a low of $60.65.

As of this writing, CRI has an earnings estimate of $Salesforce, Inc. per share for the current quarter. EPS was calculated based on a consensus of CRISPR Therapeutics AG estimates, with a high estimate of $Crown Castle Inc. per share and a lower estimate of $Canadian National Railway Compa.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CRI’s latest balance sheet shows that the firm has $984.29M in Cash & Short Term Investments as of fiscal 2021. There were $1.57B in debt and $717.23M in liabilities at the time. Its Book Value Per Share was $21.24, while its Total Shareholder’s Equity was $950.19M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRI is Buy with a score of 2.40.

Most Popular

Related Posts